Regulatory S16 Ep43: FDA Approval Insights: Rucaparib for BRCA Mutation-Associated mCRPC: With David Morris, MD, FACS; and Alan H. Bryce, MD OncLive PodcastWelcome to OncLive On Air !RegulatoryOncologyRead full story pharminent March 31, 2026 (Last updated: April 1, 2026) OncLive Podcast Welcome to OncLive On Air ! RegulatoryOncologyRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Novo hits back at rivals with cut-price Wegovy subscriptionsNext: NHS to offer Wegovy to a million more people in England Related Stories Regulatory FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients pharminent June 2, 2026 Regulatory FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy pharminent June 1, 2026 Regulatory Replimune gives cancer immunotherapy a third try after FDA leadership shakeup pharminent May 29, 2026
